In this interview, Olga Baker, PhD, DDS, focuses on the treatment of Sjogren’s syndrome, discussing the limitations of current methods and the potential of SPMs like resolvin D1 to reduce inflammation and aid tissue restoration. Dr. Baker also expresses optimism about the future of research in this field, highlighting the importance of translating findings from animal models to human treatments.
Olga Baker, PhD, DDS, is a Professor of Otolaryngology at the University of Missouri, School of Medicine.
